Pharmaceutical active ingredient with a known THC content (150 mg / ml; CBD <1%), authorized by AIFA (Italian Medicines Agency), produced and packaged in Italy in the Farmalabor pharmaceutical shop in accordance with the EU-GMP Guidelines Vol. 4 part II.